The combination tablet is approved to treat adults with hepatitis C genotypes 1-6 without cirrhosis or mild cirrhosis.
Hepatitis/MASH
Latest News
Advertisement
CME Content
Advertisement
New cases of hepatitis C virus increased among young men by 55% in 2015.
Opioids have caused more than 70% of health events among patients with drug use disorder around the world.
Selective oral immunomodulator plus tenofovir alafenamide (Vemlidy) seeks functional cure in chronic HBV.
Top news of the day from across the health care landscape.
No data were presented for treatment-naïve and pretreated adolescents with hepatitis B virus.
Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.
Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, explores the benefits of incorporating specialty pharmacists into care teams.
Differences in major risk factors and inequalities in health care access have resulted in substantial disparities in liver cancer mortality.
How NS5A inhibitors block hepatitis C virus replication impacts treatment outcomes.
Research team will seek to develop a novel prophylactic vaccine to prevent HCV.
HCV drug greatly reduced the rates of liver transplants and mortality in patients with advanced stages of cirrhosis.
The contaminated fish was sourced from Sustainable Seafood Company and Santa Cruz Seafood.
Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.
Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.
Study provides picture of host cell pathway mobilization to HCV.
In this clip, Jennifer Strohecker, PharmD, BCPS, Sr. Director MHI Pharmacy, Clinical Operations, Molina Healthcare, Inc. discusses the challenges involved in treating patients with hepatitis C.
In this clip, Jennifer Strohecker, PharmD, BCPS, who is Senior Director MHI Pharmacy, Clinical Operations, discusses a high touch model of care.
The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.
The Guide to Hepatitis C Testing summarizes the latest examination recommendations.
The criminalization of drug use could be detrimental to HIV patient health and does not decrease use, study suggests.
Chronic hepatitis C virus (HCV) infection, estimated to affect up to 4 million Americans, is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplant.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
